Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare News Papua New Guinea.
Press releases published on August 8, 2025

Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2025
Tokyo, Japan and Cambridge, UK, 8 August 2025 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the second quarter and first half ended 30 June 2025. The full report …

Nicox Extends Existing Flexible Equity Financing
5 million shares added to the existing equity financing line with Vester Finance NCX 470 Denali confirmatory Phase 3 results expected mid-August to mid-September 2025 August 08, 2025 – release at 7:30 am Sophia Antipolis, France Nicox SA (Euronext Growth …

Nicox étend sa ligne de financement flexible existante
5 millions d’actions ajoutées à la ligne de financement en fonds propres existante avec Vester Finance Les premiers résultats de l’étude confirmatoire de Phase 3 Denali sur NCX 470 sont attendus entre mi-août et mi-septembre 2025 08 août 2025 – publication …

Public and Private Sectors Unite to Enhance Vision Care Access for Patients in Need Ahead of SG60
SINGAPORE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- In a move that reflects Singapore’s commitment to inclusive healthcare and smarter service delivery, the Singapore National Eye Centre (SNEC) and OneSight EssilorLuxottica Foundation have come together to …

Market Forecast News: Pressure Monitoring to Hit $25.48B by 2032 | MarketsandMarkets™.
Delray Beach, FL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The global pressure monitoring market, valued at US$13.63 billion in 2024 stood at US$14.56 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2032, culminating in a …

BioVie Inc. Announces Pricing of $12 Million Public Offering
CARSON CITY, Nev., Aug. 07, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI, BIVIW), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and …

Heartflow, Inc. Announces Pricing of Upsized Initial Public Offering
MOUNTAIN VIEW, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the pricing of its upsized initial public offering of 16,666,667 shares of its …

Specialty Enzymes Market to Reach $9.2 Billion by 2029, Driven by Biotech Innovation and Public Funding
Delray Beach, FL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- According to a research report published by MarketsandMarkets, "Specialty Enzymes Market by Source (Microorganism, Plant, Animal), Type (Carbohydrases, Proteases, Lipases, Polymerases …